The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway

被引:70
作者
Roumier, T
Vieira, HLA
Castedo, M
Ferri, KF
Boya, P
Andreau, K
Druillennec, S
Joza, N
Penninger, JM
Roques, B
Kroemer, G
机构
[1] Inst Gustave Roussy, CNRS UMR1599, F-94805 Villejuif, France
[2] Univ Paris 05, CNRS UMR860, INSERM U266, Unite Pharmacochim Mol & Struct, F-75005 Paris, France
[3] Univ Toronto, Dept Med Biophys & Immunol, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada
[4] Univ Toronto, Amgen Inst, Toronto, ON M5G 2C1, Canada
关键词
apoptosis; adenine nucleoticle translocator; cytomegalovirus; human immunodeficiency virus;
D O I
10.1038/sj.cdd.4401089
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Previous biochemical studies suggested that HIV-1-encoded Vpr may kill cells through an effect on the adenine nucleotide translocase (ANT), thereby causing mitochondrial membrane permeabilization (MMP). Here, we show that Vpr fails to activate caspases in conditions in which it induces cell killing. The knock-out of essential caspase-activators (Apaf-1 or caspase-9) or the knock-out of a mitochondrial caspase-independent death effector (AIF) does not abolish Vpr-mediated killing. In contrast, the cytotoxic effects of Vpr are reduced by transfection-enforced overexpression of two MMP-inhibitors, namely the endogenous protein Bcl-2 or the cytomegalovirus-encoded ANT-targeted protein vMIA. Vpr, which can elicit MMP through a direct effect on mitochondria, and HIV-1-Env, which causes MMP through an indirect pathway, exhibit additive (but not synergic) cytotoxic effects. In conclusion, it appears that Vpr induces apoptosis through a caspase-independent mitochondrial pathway.
引用
收藏
页码:1212 / 1219
页数:8
相关论文
共 53 条
[1]   Endoplasmic reticulum localized Bcl-2 prevents apoptosis when redistribution of cytochrome c is a late event [J].
Annis, MG ;
Zamzami, N ;
Zhu, WJ ;
Penn, LZ ;
Kroemer, G ;
Leber, B ;
Andrews, DW .
ONCOGENE, 2001, 20 (16) :1939-1952
[2]   A C-terminal domain of HIV-1-accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4(+) lymphocytes [J].
Arunagiri, C ;
Macreadie, I ;
Hewish, D ;
Azad, A .
APOPTOSIS, 1997, 2 (01) :69-76
[3]   HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B [J].
Ayyavoo, V ;
Mahboubi, A ;
Mahalingam, S ;
Ramalingam, R ;
Kudchodkar, S ;
Williams, WV ;
Green, DR ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (10) :1117-1123
[4]   HIV-1 viral protein R compromises cellular immune function in vivo [J].
Ayyavoo, V ;
Muthumani, K ;
Kudchodkar, S ;
Zhang, DH ;
Ramanathan, P ;
Dayes, NS ;
Kim, JJ ;
Sin, JI ;
Montaner, LJ ;
Weiner, DB .
INTERNATIONAL IMMUNOLOGY, 2002, 14 (01) :13-22
[5]   Mechanisms of HIV-associated lymphocyte apoptosis [J].
Badley, AD ;
Pilon, AA ;
Landay, A ;
Lynch, DH .
BLOOD, 2000, 96 (09) :2951-2964
[6]   Viral and bacterial proteins regulating apoptosis at the mitochondrial level [J].
Boya, P ;
Roques, B ;
Kroemer, G .
EMBO JOURNAL, 2001, 20 (16) :4325-4331
[7]   Biochemical pathways of caspase activation during apoptosis [J].
Budihardjo, I ;
Oliver, H ;
Lutter, M ;
Luo, X ;
Wang, XD .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1999, 15 :269-290
[8]   Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target. of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation [J].
Castedo, M ;
Ferri, KF ;
Blanco, J ;
Roumier, T ;
Larochette, N ;
Barretina, J ;
Amendola, A ;
Nardacci, R ;
Métivier, D ;
Este, JA ;
Piacentini, M ;
Kroemer, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (08) :1097-1110
[9]   BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis [J].
Cheng, EHYA ;
Wei, MC ;
Weiler, S ;
Flavell, RA ;
Mak, TW ;
Lindsten, T ;
Korsmeyer, SJ .
MOLECULAR CELL, 2001, 8 (03) :705-711
[10]  
COMILLE F, 1999, J PEPT RES, V54, P427